Katrina S. Pedersen, MD, MS
A new set of recommendations for the treatment of small bowel adenocarcinoma (SBA), a relatively rare type cancer of the gastrointestinal (GI) tract, have been created by the National Comprehensive Cancer Network (NCCN). The guidelines are the first in the United States and second in the world to recommend treatments specific to the malignancy, which is often diagnosed at advanced stages. Table.
Juan C. Camacho, MD
Patients with neuroendocrine tumors (NETs) that have metastasized to the liver derive clinical benefit from locoregional therapies, but treatment guidelines for employing these strategies must be more fully developed, according to Juan C. Camacho, MD. ... to read the full story
D. Ross Camidge, MD, PhD
Four tumor serum markers commonly used in other solid tumors could be used in monitoring therapeutic outcomes in patients with stage IV lung adenocarcinoma, according to a single-center retrospective analysis. The markers studied were carcinoembryonic antigen (CEA), CA125, CA19.9, and CA27.29.